ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
13.64
-0.47 (-3.33%)
At close: May 12, 2025, 4:00 PM
14.01
+0.37 (2.71%)
After-hours: May 12, 2025, 5:49 PM EDT
ClearPoint Neuro Revenue
In the year 2024, ClearPoint Neuro had annual revenue of $31.39M with 31.04% growth. ClearPoint Neuro had revenue of $7.77M in the quarter ending December 31, 2024, with 14.11% growth.
Revenue (ttm)
$31.39M
Revenue Growth
+31.04%
P/S Ratio
11.74
Revenue / Employee
$272,957
Employees
115
Market Cap
381.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.39M | 7.44M | 31.04% |
Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CLPT News
- 8 hours ago - ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing - Accesswire
- 14 days ago - ClearPoint Neuro: Fundamentals Continue To Strengthen - Seeking Alpha
- 14 days ago - ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI - Accesswire
- 17 days ago - ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 - Accesswire
- 18 days ago - ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room - Accesswire
- 2 months ago - ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen - Seeking Alpha
- 2 months ago - ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results - Accesswire